These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13718672)

  • 21. Modification of tumor microcirculation as an adjunct to hyperbaric oxygen in radiotherapy.
    Evans JC; Gable PV
    Radiology; 1967 Jul; 89(1):140-2. PubMed ID: 6027320
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction between heparin and adriamycin in mice bearing the Lewis lung carcinoma.
    Colombo T; Delaini F; Ferrari R; Donati MB; Donelli MG; Poggi A
    Biomedicine; 1981 Dec; 34(3):124-8. PubMed ID: 7337798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of heparin, coumarin and -aminocaproic acid (EACA) on spontaneous metastasis formation. Influence on the moment of metastasis formation. Possible cytotoxic effect of heparin and coumarin in blood.
    Hagmar B
    Pathol Eur; 1969; 4(3):283-92. PubMed ID: 5403819
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties.
    Lapierre F; Holme K; Lam L; Tressler RJ; Storm N; Wee J; Stack RJ; Castellot J; Tyrrell DJ
    Glycobiology; 1996 Apr; 6(3):355-66. PubMed ID: 8724143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental studies of factors which influence hepatic metastases. VII. Efect of anticoagulants.
    FISHER B; FISHER ER
    Surgery; 1961 Jul; 50():240-7. PubMed ID: 13699932
    [No Abstract]   [Full Text] [Related]  

  • 26. THE EFFECTS OF FIBRIN FORMATION AND ALTERATIONS IN THE CLOTTING MECHANISM ON THE DEVELOPMENT OF METASTASES.
    CLIFFTON EE; AGOSTINO D
    Vasc Dis; 1965 Jan; 2():43-52. PubMed ID: 14252944
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiangiogenic and apoptotic properties of a novel amphiphilic folate-heparin-lithocholate derivative having cellular internality for cancer therapy.
    Yu MK; Lee DY; Kim YS; Park K; Park SA; Son DH; Lee GY; Nam JH; Kim SY; Kim IS; Park RW; Byun Y
    Pharm Res; 2007 Apr; 24(4):705-14. PubMed ID: 17318418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis.
    Matsuzaki K; Yoshitake Y; Matuo Y; Sasaki H; Nishikawa K
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9911-5. PubMed ID: 2481318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of heparin and warfarin on primary and metastatic tumors.
    Millar RC; Ketcham AS
    J Med; 1974; 5(1):23-31. PubMed ID: 4598770
    [No Abstract]   [Full Text] [Related]  

  • 30. ACTIVATION OF A FIBRINOLYTIC SYSTEM IN A DOG WITH MAST CELL TUMOR.
    ENDE N; AUDITORE JV
    Am J Physiol; 1964 Mar; 206():567-72. PubMed ID: 14160986
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the problem of endogenous tumor resistance].
    Landsberger A
    Landarzt; 1965 Nov; 41(33):1425-8. PubMed ID: 5886101
    [No Abstract]   [Full Text] [Related]  

  • 32. Extrapulmonary colony formation after intravenous injection of tumour cells into heparin-treated animals.
    Maat B
    Br J Cancer; 1978 Mar; 37(3):369-76. PubMed ID: 638015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the effects of unfractionated heparin, dalteparin and danaparoid on vascular endothelial growth factor-induced tumour angiogenesis and heparanase activity.
    Takahashi H; Ebihara S; Okazaki T; Asada M; Sasaki H; Yamaya M
    Br J Pharmacol; 2005 Oct; 146(3):333-43. PubMed ID: 16041398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INTERFERENCE IN LOCALIZATION OF I-131 FIBRINOGEN IN RAT TUMORS BY ANTICOAGULANTS.
    SHAEFFER JR
    Am J Physiol; 1964 Mar; 206():573-9. PubMed ID: 14160987
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppression of experimental tumor seeding by biocidal sutures.
    Stephens FO
    Surgery; 1971 Sep; 70(3):348-52. PubMed ID: 5568518
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of heparin induced anti-cancer activity in experimental cancer models.
    Niers TM; Klerk CP; DiNisio M; Van Noorden CJ; Büller HR; Reitsma PH; Richel DJ
    Crit Rev Oncol Hematol; 2007 Mar; 61(3):195-207. PubMed ID: 17074500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES.
    CLIFFTON EE; AGOSTINO D
    J Natl Cancer Inst; 1964 Nov; 33():753-63. PubMed ID: 14231149
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative effects of dicoumarol, tromexan, and heparin on thrombus propagation.
    CAREY LC; WILLIAMS RD
    Ann Surg; 1960 Nov; 152(5):919-22. PubMed ID: 13690778
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative effect of heparin and other agents on traumatic shock in the rat.
    BANASZAK EF; STEKIEL WJ; SMITH JJ
    Am J Physiol; 1959 Nov; 197():989-92. PubMed ID: 13796360
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumour angiogenesis.
    Gelister JS; Lewin MR; Boulos PB
    Ann R Coll Surg Engl; 1986 May; 68(3):172-3. PubMed ID: 2425695
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.